Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.15 trillion and total revenue of $105.3 billion.
Market Cap
1.15T
Revenue
105.3B
Profits
-41.5B
PE Ratio
n/a
Profit Margin
-39.41%
Dividend Yield
0.05%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 117.00B | 1.35% | 1,514,019 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.51B | 0.82% | 760,048 | 14.25B |
| 3 | ARGX | argenx SE | 50.26B | 1.30% | 415,195 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 48.88B | 1.24% | 1,864,806 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 37.49B | -0.83% | 242,762 | 4.97B |
| 6 | INSM | Insmed Incorporated | 34.21B | 2.60% | 2,701,732 | 447.02M |
| 7 | BNTX | BioNTech SE | 29.73B | 0.40% | 1,592,418 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 23.15B | 0.98% | 4,987,830 | 2.35B |
| 9 | RVMD | Revolution Medicines, Inc. | 22.97B | 1.09% | 3,171,510 | - |
| 10 | INCY | Incyte Corporation | 20.63B | 0.37% | 1,305,628 | 4.81B |
| 11 | GMAB | Genmab A/S | 20.51B | 0.46% | 1,167,085 | 3.85B |
| 12 | MRNA | Moderna, Inc. | 20.27B | 4.14% | 34,070,729 | 2.23B |
| 13 | ROIV | Roivant Sciences Ltd. | 15.98B | -0.04% | 3,214,399 | 20.33M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 15.40B | 2.25% | 2,712,694 | 353.78M |
| 15 | ASND | Ascendis Pharma A/S | 14.03B | 5.53% | 1,223,234 | 758.59M |
| 16 | SMMT | Summit Therapeutics Inc. | 13.39B | 3.09% | 3,540,994 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 13.26B | 3.06% | 3,705,700 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 11.98B | -0.69% | 2,200,217 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.31B | 0.22% | 220,607 | 740.64M |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 10.99B | 0.72% | 2,049,599 | 3.09B |
| 21 | RNA | Avidity Biosciences, Inc. | 10.96B | 0.12% | 1,940,661 | 20.87M |
| 22 | TECH | Bio-Techne Corporation | 10.85B | -2.40% | 2,453,564 | 1.22B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.39B | 1.09% | 1,202,190 | 4.16B |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.56B | 2.94% | 2,123,177 | 829.45M |
| 25 | ABVX | ABIVAX Société Anonyme | 9.51B | 3.02% | 1,072,582 | 6.23M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 9.43B | -1.12% | 621,471 | 561.26M |
| 27 | NUVL | Nuvalent, Inc. | 8.70B | 2.71% | 855,354 | - |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 8.44B | -2.63% | 434,452 | 7.46M |
| 29 | KRYS | Krystal Biotech, Inc. | 8.38B | 1.09% | 211,790 | 373.16M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.38B | -0.59% | 842,354 | 1.24B |
| 31 | CYTK | Cytokinetics, Incorporated | 7.94B | 3.00% | 1,506,066 | 87.21M |
| 32 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.24B | 2.34% | 557,033 | 174.33M |
| 33 | IBRX | ImmunityBio, Inc. | 7.23B | 6.07% | 80,700,449 | 82.56M |
| 34 | CAI | Caris Life Sciences, Inc. | 7.21B | 0.27% | 2,184,252 | 649.06M |
| 35 | PCVX | Vaxcyte, Inc. | 7.05B | 7.19% | 2,268,924 | - |
| 36 | GPCR | Structure Therapeutics Inc. | 6.35B | -2.05% | 1,214,993 | - |
| 37 | PTCT | PTC Therapeutics, Inc. | 6.12B | 0.81% | 887,799 | 1.78B |
| 38 | COGT | Cogent Biosciences, Inc. | 6.01B | -0.93% | 5,424,372 | - |
| 39 | BLTE | Belite Bio, Inc | 6.00B | 0.41% | 106,912 | - |
| 40 | KYMR | Kymera Therapeutics, Inc. | 5.82B | 2.87% | 562,934 | 43.74M |
| 41 | CRSP | CRISPR Therapeutics AG | 5.80B | 11.11% | 3,420,083 | 38.34M |
| 42 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.63B | -0.83% | 1,122,009 | 1.54M |
| 43 | APGE | Apogee Therapeutics, Inc. | 5.39B | -2.50% | 644,383 | - |
| 44 | IMVT | Immunovant, Inc. | 5.31B | 0.61% | 1,646,741 | - |
| 45 | PTGX | Protagonist Therapeutics, Inc. | 5.30B | 1.07% | 609,076 | 209.22M |
| 46 | CELC | Celcuity Inc. | 5.13B | 3.37% | 448,686 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 4.96B | 2.96% | 774,309 | 471.79M |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.87B | 3.71% | 1,233,355 | - |
| 49 | ACAD | ACADIA Pharmaceuticals Inc. | 4.65B | 2.80% | 1,435,449 | 1.05B |
| 50 | TGTX | TG Therapeutics, Inc. | 4.62B | 0.19% | 1,611,342 | 531.90M |
| 51 | CGON | CG Oncology, Inc. | 4.51B | -2.24% | 3,130,444 | 2.17M |
| 52 | FOLD | Amicus Therapeutics, Inc. | 4.41B | -0.56% | 10,838,533 | 598.70M |
| 53 | CORT | Corcept Therapeutics Incorporated | 4.34B | 13.74% | 5,893,063 | 741.17M |
| 54 | ADMA | ADMA Biologics, Inc. | 4.14B | 0.23% | 2,260,237 | 488.56M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 4.01B | 2.12% | 311,257 | 251.23M |
| 56 | ACLX | Arcellx, Inc. | 3.99B | 0.09% | 1,618,747 | 35.90M |
| 57 | NAMS | NewAmsterdam Pharma Company N.V. | 3.95B | 2.56% | 410,713 | 35.24M |
| 58 | TERN | Terns Pharmaceuticals, Inc. | 3.91B | -1.88% | 2,033,929 | - |
| 59 | VKTX | Viking Therapeutics, Inc. | 3.85B | 2.13% | 3,014,880 | - |
| 60 | CNTA | Centessa Pharmaceuticals plc | 3.60B | 6.11% | 2,037,770 | 15.00M |
| 61 | LQDA | Liquidia Corporation | 3.57B | 2.71% | 2,049,911 | 69.22M |
| 62 | LEGN | Legend Biotech Corporation | 3.57B | -6.84% | 5,601,047 | 909.05M |
| 63 | VERA | Vera Therapeutics, Inc. | 3.46B | 6.43% | 1,135,489 | - |
| 64 | BEAM | Beam Therapeutics Inc. | 3.38B | 10.09% | 3,738,350 | 55.70M |
| 65 | ALMS | Alumis Inc. | 3.28B | -1.50% | 1,741,374 | 22.12M |
| 66 | DNLI | Denali Therapeutics Inc. | 3.27B | 12.53% | 3,087,063 | - |
| 67 | ARQT | Arcutis Biotherapeutics, Inc. | 3.26B | -0.19% | 1,699,208 | 317.93M |
| 68 | XENE | Xenon Pharmaceuticals Inc. | 3.26B | 3.02% | 1,275,632 | 7.50M |
| 69 | IDYA | IDEAYA Biosciences, Inc. | 3.17B | 0.43% | 763,772 | 214.83M |
| 70 | EWTX | Edgewise Therapeutics, Inc. | 3.15B | 1.85% | 1,138,480 | - |
| 71 | VRDN | Viridian Therapeutics, Inc. | 3.07B | -0.31% | 1,852,114 | 70.79M |
| 72 | TARS | Tarsus Pharmaceuticals, Inc. | 3.02B | -0.20% | 471,086 | 366.10M |
| 73 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.01B | 1.33% | 862,808 | 578.20M |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.98B | 3.31% | 2,866,524 | - |
| 75 | IRON | Disc Medicine, Inc. | 2.95B | 4.42% | 731,357 | - |
| 76 | ERAS | Erasca, Inc. | 2.92B | 2.39% | 10,941,700 | - |
| 77 | ADPT | Adaptive Biotechnologies Corporation | 2.91B | 8.48% | 2,240,463 | 252.75M |
| 78 | RCUS | Arcus Biosciences, Inc. | 2.85B | 0.48% | 1,045,346 | 240.00M |
| 79 | IMNM | Immunome, Inc. | 2.85B | 3.82% | 2,860,263 | 9.68M |
| 80 | APLS | Apellis Pharmaceuticals, Inc. | 2.78B | 5.01% | 2,893,197 | 1.02B |
| 81 | MLYS | Mineralys Therapeutics, Inc. | 2.71B | 9.49% | 1,444,112 | - |
| 82 | TVTX | Travere Therapeutics, Inc. | 2.66B | 5.24% | 1,718,314 | 435.83M |
| 83 | SYRE | Spyre Therapeutics, Inc. | 2.65B | 0.29% | 847,475 | - |
| 84 | RXRX | Recursion Pharmaceuticals, Inc. | 2.58B | 7.59% | 36,236,507 | 43.69M |
| 85 | WVE | Wave Life Sciences Ltd. | 2.53B | -0.86% | 3,441,810 | 109.23M |
| 86 | TLX | Telix Pharmaceuticals Limited | 2.53B | 4.24% | 166,371 | 664.23M |
| 87 | OCUL | Ocular Therapeutix, Inc. | 2.37B | -2.63% | 3,712,258 | 55.78M |
| 88 | SLNO | Soleno Therapeutics, Inc. | 2.35B | 0.44% | 1,405,692 | 98.68M |
| 89 | AAPG | Ascentage Pharma Group International | 2.34B | -3.30% | 885 | 54.52M |
| 90 | MESO | Mesoblast Limited | 2.33B | 8.12% | 202,695 | 17.20M |
| 91 | SRPT | Sarepta Therapeutics, Inc. | 2.28B | 1.97% | 2,016,571 | 2.41B |
| 92 | GLPG | Galapagos NV | 2.27B | 2.69% | 122,294 | 336.64M |
| 93 | DNTH | Dianthus Therapeutics, Inc. | 2.27B | 10.04% | 1,367,946 | 3.08M |
| 94 | RARE | Ultragenyx Pharmaceutical Inc. | 2.25B | 2.86% | 2,323,773 | 630.60M |
| 95 | MAZE | Maze Therapeutics, Inc. | 2.22B | 5.72% | 491,921 | 2.50M |
| 96 | HRMY | Harmony Biosciences Holdings, Inc. | 2.12B | 0.19% | 816,568 | 825.94M |
| 97 | OLMA | Olema Pharmaceuticals, Inc. | 2.08B | 0.49% | 1,390,901 | - |
| 98 | ZLAB | Zai Lab Limited | 2.04B | -2.49% | 881,538 | 441.63M |
| 99 | NUVB | Nuvation Bio Inc. | 2.03B | -3.90% | 8,751,513 | 26.75M |
| 100 | VCEL | Vericel Corporation | 1.98B | 3.76% | 494,386 | 258.72M |
| 101 | NRIX | Nurix Therapeutics, Inc. | 1.97B | 1.95% | 1,425,510 | 83.69M |
| 102 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | 0.54% | 679,954 | 265.81M |
| 103 | ARDX | Ardelyx, Inc. | 1.93B | -0.75% | 4,781,640 | 398.23M |
| 104 | CRVS | Corvus Pharmaceuticals, Inc. | 1.91B | 15.21% | 12,830,433 | - |
| 105 | MBX | MBX Biosciences, Inc. | 1.90B | 3.16% | 792,844 | - |
| 106 | SION | Sionna Therapeutics, Inc. | 1.86B | 2.40% | 600,163 | - |
| 107 | NTLA | Intellia Therapeutics, Inc. | 1.84B | 13.33% | 10,506,699 | 57.53M |
| 108 | BHVN | Biohaven Ltd. | 1.83B | 6.92% | 2,809,708 | - |
| 109 | GLUE | Monte Rosa Therapeutics, Inc. | 1.82B | -4.99% | 1,949,061 | 181.54M |
| 110 | PHVS | Pharvaris N.V. | 1.82B | 1.74% | 248,421 | - |
| 111 | MNKD | MannKind Corporation | 1.81B | 3.50% | 5,719,476 | 313.79M |
| 112 | SNDX | Syndax Pharmaceuticals, Inc. | 1.81B | 1.32% | 1,294,484 | 111.30M |
| 113 | CLDX | Celldex Therapeutics, Inc. | 1.78B | 2.60% | 322,999 | 2.60M |
| 114 | IMCR | Immunocore Holdings plc | 1.77B | -0.74% | 642,433 | 379.59M |
| 115 | ZYME | Zymeworks Inc. | 1.76B | -1.67% | 590,389 | 134.48M |
| 116 | KOD | Kodiak Sciences Inc. | 1.74B | 4.98% | 804,360 | - |
| 117 | ORKA | Oruka Therapeutics, Inc. | 1.72B | 3.11% | 996,871 | - |
| 118 | UPB | Upstream Bio, Inc. | 1.72B | 0.63% | 402,365 | 2.80M |
| 119 | STOK | Stoke Therapeutics, Inc. | 1.72B | 1.86% | 705,570 | 205.63M |
| 120 | PGEN | Precigen, Inc. | 1.71B | 8.52% | 7,772,394 | 6.31M |
| 121 | DFTX | Definium Therapeutics, Inc. | 1.67B | -1.05% | 3,150,135 | - |
| 122 | AGIO | Agios Pharmaceuticals, Inc. | 1.67B | 5.48% | 791,995 | 44.79M |
| 123 | RAPT | RAPT Therapeutics, Inc. | 1.67B | 0.05% | 2,638,547 | - |
| 124 | TNGX | Tango Therapeutics, Inc. | 1.66B | -1.28% | 2,902,282 | 66.50M |
| 125 | TYRA | Tyra Biosciences, Inc. | 1.65B | 5.03% | 1,219,953 | - |
| 126 | FTRE | Fortrea Holdings Inc. | 1.60B | 2.06% | 550,867 | 2.76B |
| 127 | ELVN | Enliven Therapeutics, Inc. | 1.60B | -0.75% | 1,466,386 | - |
| 128 | NVAX | Novavax, Inc. | 1.58B | -1.52% | 9,350,383 | 1.06B |
| 129 | SVRA | Savara Inc. | 1.56B | 4.52% | 1,489,889 | - |
| 130 | OCS | Oculis Holding AG | 1.55B | 2.69% | 318,253 | 992.00K |
| 131 | INVA | Innoviva, Inc. | 1.48B | 0.71% | 702,486 | 388.52M |
| 132 | ATAI | AtaiBeckley Inc. | 1.44B | 1.79% | 2,968,343 | 3.02M |
| 133 | QURE | uniQure N.V. | 1.41B | 4.37% | 1,538,211 | 15.75M |
| 134 | TRVI | Trevi Therapeutics, Inc. | 1.40B | 6.21% | 2,410,190 | - |
| 135 | TSHA | Taysha Gene Therapies, Inc. | 1.39B | 6.49% | 2,449,954 | 6.31M |
| 136 | ABCL | AbCellera Biologics Inc. | 1.39B | 8.41% | 6,944,461 | 35.33M |
| 137 | IMTX | Immatics N.V. | 1.36B | 1.70% | 357,356 | 99.45M |
| 138 | PHAR | Pharming Group N.V. | 1.36B | 10.99% | 37,024 | 362.27M |
| 139 | EYPT | EyePoint, Inc. | 1.35B | 5.18% | 1,361,384 | 42.34M |
| 140 | SANA | Sana Biotechnology, Inc. | 1.34B | 5.36% | 4,040,310 | - |
| 141 | RAPP | Rapport Therapeutics, Inc. | 1.33B | 5.76% | 418,559 | - |
| 142 | DBVT | DBV Technologies S.A. | 1.32B | 6.32% | 942,139 | 5.50M |
| 143 | RLAY | Relay Therapeutics, Inc. | 1.32B | 0.80% | 3,956,154 | 8.36M |
| 144 | ANAB | AnaptysBio, Inc. | 1.31B | 1.39% | 263,011 | 169.47M |
| 145 | IVA | Inventiva S.A. | 1.28B | 7.29% | 806,450 | 19.93M |
| 146 | DAWN | Day One Biopharmaceuticals, Inc. | 1.27B | 2.24% | 3,481,537 | 133.67M |
| 147 | XERS | Xeris Biopharma Holdings, Inc. | 1.26B | -0.13% | 1,409,427 | 266.14M |
| 148 | CAPR | Capricor Therapeutics, Inc. | 1.25B | -0.58% | 711,131 | 11.13M |
| 149 | SEPN | Septerna, Inc. | 1.20B | 1.33% | 246,661 | 22.05M |
| 150 | AKTS | Aktis Oncology, Inc. | 1.18B | 9.80% | 432,608 | 5.56M |
| 151 | ORIC | ORIC Pharmaceuticals, Inc. | 1.17B | -1.63% | 1,170,825 | - |
| 152 | INBX | Inhibrx Biosciences, Inc. | 1.16B | 5.85% | 303,780 | 1.40M |
| 153 | CMPX | Compass Therapeutics, Inc. | 1.12B | 6.27% | 3,539,923 | 850.00K |
| 154 | MLTX | MoonLake Immunotherapeutics | 1.11B | -6.52% | 1,587,176 | - |
| 155 | PHAT | Phathom Pharmaceuticals, Inc. | 1.11B | 4.26% | 1,271,730 | 147.19M |
| 156 | ZBIO | Zenas BioPharma, Inc. | 1.10B | 4.13% | 900,371 | 15.00M |
| 157 | PVLA | Palvella Therapeutics, Inc. | 1.09B | -1.87% | 172,586 | - |
| 158 | IOVA | Iovance Biotherapeutics, Inc. | 1.07B | 7.17% | 13,713,625 | 250.43M |
| 159 | TBPH | Theravance Biopharma, Inc. | 1.05B | 1.82% | 339,876 | 80.33M |
| 160 | SPRY | ARS Pharmaceuticals, Inc. | 1.04B | 1.25% | 1,326,534 | 142.77M |
| 161 | AVBP | ArriVent BioPharma, Inc. | 1.04B | 10.14% | 769,807 | - |
| 162 | GHRS | GH Research PLC | 1.04B | 2.20% | 187,049 | - |
| 163 | ANNX | Annexon, Inc. | 1.04B | 1.61% | 2,780,262 | - |
| 164 | NBTX | Nanobiotix S.A. | 1.03B | 6.58% | 4,734 | 11.93M |
| 165 | VIR | Vir Biotechnology, Inc. | 1.03B | 6.63% | 2,798,243 | 16.86M |
| 166 | VTYX | Ventyx Biosciences, Inc. | 998.76M | 0.36% | 1,610,951 | - |
| 167 | MRVI | Maravai LifeSciences Holdings, Inc. | 979.36M | - | 1,355,931 | 192.44M |
| 168 | CTMX | CytomX Therapeutics, Inc. | 969.17M | 8.13% | 5,796,638 | 113.63M |
| 169 | BCAX | Bicara Therapeutics Inc. | 963.61M | 3.65% | 424,983 | - |
| 170 | XNCR | Xencor, Inc. | 936.19M | 0.85% | 701,235 | 150.13M |
| 171 | URGN | UroGen Pharma Ltd. | 936.18M | 4.00% | 778,720 | 96.52M |
| 172 | JANX | Janux Therapeutics, Inc. | 910.64M | 14.09% | 6,189,925 | 10.00M |
| 173 | GERN | Geron Corporation | 900.08M | 5.22% | 11,470,697 | 183.40M |
| 174 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 899.87M | -1.23% | 164,262 | - |
| 175 | VALN | Valneva SE | 893.67M | 2.97% | 14,966 | 211.09M |
| 176 | YDES | YD Bio Limited | 871.97M | 3.33% | 61,991 | 510.36K |
| 177 | OMER | Omeros Corporation | 861.44M | 0.58% | 2,064,412 | - |
| 178 | KALV | KalVista Pharmaceuticals, Inc. | 836.04M | 3.96% | 733,839 | 1.43M |
| 179 | PRME | Prime Medicine, Inc. | 827.65M | 16.58% | 5,000,905 | 5.98M |
| 180 | MPLT | MapLight Therapeutics, Inc. | 810.86M | 9.62% | 345,685 | - |
| 181 | RGNX | REGENXBIO Inc. | 808.96M | 6.39% | 808,854 | 161.32M |
| 182 | ARVN | Arvinas, Inc. | 807.30M | -0.24% | 698,057 | 312.30M |
| 183 | MDXG | MiMedx Group, Inc. | 802.71M | 1.69% | 917,966 | 393.44M |
| 184 | ABUS | Arbutus Biopharma Corporation | 800.07M | 0.48% | 831,543 | 14.61M |
| 185 | DRUG | Bright Minds Biosciences Inc. | 799.11M | 5.06% | 122,481 | - |
| 186 | KURA | Kura Oncology, Inc. | 790.99M | 4.24% | 1,172,006 | 104.03M |
| 187 | JBIO | Jade Biosciences, Inc. | 782.99M | 6.78% | 160,106 | - |
| 188 | SLS | SELLAS Life Sciences Group, Inc. | 767.97M | -1.53% | 5,601,554 | - |
| 189 | NKTR | Nektar Therapeutics | 743.08M | -1.06% | 600,402 | 62.60M |
| 190 | CGEM | Cullinan Therapeutics, Inc. | 742.59M | 8.36% | 1,384,118 | - |
| 191 | GYRE | Gyre Therapeutics, Inc. | 731.67M | -3.01% | 67,200 | 107.27M |
| 192 | FULC | Fulcrum Therapeutics, Inc. | 728.97M | 6.05% | 720,686 | 80.00M |
| 193 | ATXS | Astria Therapeutics, Inc. | 718.13M | 0.64% | 3,153,287 | 706.00K |
| 194 | ENGN | enGene Holdings Inc. | 712.72M | 13.92% | 1,078,745 | - |
| 195 | NBY | NovaBay Pharmaceuticals, Inc. | 690.54M | -6.64% | 1,274,529 | 10.30M |
| 196 | RIGL | Rigel Pharmaceuticals, Inc. | 688.48M | 0.77% | 242,726 | 282.08M |
| 197 | VOR | Vor Biopharma Inc. | 668.70M | -4.48% | 780,355 | - |
| 198 | MGTX | MeiraGTx Holdings plc | 667.27M | 8.65% | 459,508 | 27.42M |
| 199 | LENZ | LENZ Therapeutics, Inc. | 665.54M | 9.19% | 2,524,934 | 17.50M |
| 200 | GOSS | Gossamer Bio, Inc. | 664.28M | 4.74% | 7,489,586 | 44.05M |
| 201 | PROK | ProKidney Corp. | 655.82M | 1.40% | 851,958 | 744.00K |
| 202 | LXRX | Lexicon Pharmaceuticals, Inc. | 639.58M | 12.82% | 8,304,536 | 70.86M |
| 203 | IVVD | Invivyd, Inc. | 623.19M | - | 4,114,542 | 50.04M |
| 204 | REPL | Replimune Group, Inc. | 619.70M | 8.82% | 1,203,523 | - |
| 205 | DRTS | Alpha Tau Medical Ltd. | 611.34M | 10.48% | 480,388 | - |
| 206 | DNA | Ginkgo Bioworks Holdings, Inc. | 608.15M | 9.41% | 1,380,999 | 180.61M |
| 207 | DSGN | Design Therapeutics, Inc. | 603.53M | 10.94% | 523,013 | - |
| 208 | KYTX | Kyverna Therapeutics, Inc. | 600.43M | 10.86% | 1,269,854 | - |
| 209 | TENX | Tenax Therapeutics, Inc. | 599.63M | -4.95% | 503,466 | - |
| 210 | LBRX | LB Pharmaceuticals Inc | 595.79M | 8.43% | 208,960 | - |
| 211 | EVMN | Evommune, Inc. | 595.49M | 0.21% | 169,308 | 13.00M |
| 212 | KROS | Keros Therapeutics, Inc. | 593.33M | 2.39% | 285,502 | 246.72M |
| 213 | ALT | Altimmune, Inc. | 587.25M | 16.45% | 7,952,730 | 20.00K |
| 214 | CRMD | CorMedix Inc. | 586.19M | 1.50% | 2,717,929 | 214.30M |
| 215 | FBRX | Forte Biosciences, Inc. | 570.61M | 1.59% | 169,814 | - |
| 216 | LXEO | Lexeo Therapeutics, Inc. | 560.54M | 6.22% | 902,780 | - |
| 217 | PRTA | Prothena Corporation plc | 556.60M | 6.82% | 512,585 | 11.79M |
| 218 | LYEL | Lyell Immunopharma, Inc. | 548.94M | 7.13% | 80,077 | 41.00K |
| 219 | OCGN | Ocugen, Inc. | 541.02M | 10.74% | 7,189,192 | 5.37M |
| 220 | SLDB | Solid Biosciences Inc. | 534.46M | 11.36% | 2,736,409 | - |
| 221 | ANRO | Alto Neuroscience, Inc. | 533.72M | -2.33% | 110,689 | - |
| 222 | VSTM | Verastem, Inc. | 516.35M | 5.19% | 2,627,965 | 13.38M |
| 223 | ZVRA | Zevra Therapeutics, Inc. | 511.18M | 0.55% | 1,338,616 | 84.39M |
| 224 | NAGE | Niagen Bioscience, Inc. | 502.96M | 1.29% | 638,863 | 124.71M |
| 225 | BCYC | Bicycle Therapeutics plc | 501.88M | 4.86% | 240,553 | 28.34M |
| 226 | ACRS | Aclaris Therapeutics, Inc. | 490.80M | 2.49% | 2,979,805 | 15.74M |
| 227 | MNPR | Monopar Therapeutics Inc. | 481.08M | 2.27% | 323,697 | - |
| 228 | VNDA | Vanda Pharmaceuticals Inc. | 478.68M | 2.14% | 703,701 | 212.07M |
| 229 | ABSI | Absci Corporation | 475.17M | 4.64% | 3,059,273 | 2.82M |
| 230 | AVXL | Anavex Life Sciences Corp. | 473.54M | - | 1,126,992 | - |
| 231 | ADCT | ADC Therapeutics SA | 470.73M | 6.44% | 501,384 | 75.21M |
| 232 | FDMT | 4D Molecular Therapeutics, Inc. | 462.22M | 5.20% | 556,062 | 120.00K |
| 233 | CTNM | Contineum Therapeutics, Inc. | 461.37M | 3.52% | 497,691 | - |
| 234 | EPRX | Eupraxia Pharmaceuticals Inc. | 458.46M | -0.22% | 288,227 | - |
| 235 | NBP | NovaBridge Biosciences | 448.48M | 2.64% | 926,332 | - |
| 236 | DMAC | DiaMedica Therapeutics Inc. | 446.04M | 4.45% | 260,731 | - |
| 237 | ASMB | Assembly Biosciences, Inc. | 436.87M | 4.82% | 70,178 | 37.19M |
| 238 | BNTC | Benitec Biopharma Inc. | 434.45M | 5.86% | 111,423 | - |
| 239 | PRTC | PureTech Health plc | 434.43M | 4.97% | 4,283 | 6.39M |
| 240 | TRDA | Entrada Therapeutics, Inc. | 419.94M | 3.63% | 183,684 | 61.52M |
| 241 | ZURA | Zura Bio Limited | 419.40M | 2.06% | 1,612,236 | - |
| 242 | VTVT | vTv Therapeutics Inc. | 419.05M | 2.18% | 7,061 | 17.00K |
| 243 | IMMP | Immutep Limited | 413.60M | 3.89% | 143,106 | 3.31M |
| 244 | RCKT | Rocket Pharmaceuticals, Inc. | 409.08M | 2.44% | 5,443,312 | - |
| 245 | AUTL | Autolus Therapeutics plc | 404.54M | 3.40% | 2,177,006 | 51.13M |
| 246 | LCTX | Lineage Cell Therapeutics, Inc. | 399.84M | -0.60% | 468,362 | 10.82M |
| 247 | PEPG | PepGen Inc. | 387.05M | 4.07% | 492,329 | - |
| 248 | ALLO | Allogene Therapeutics, Inc. | 386.54M | 7.50% | 5,918,133 | 22.00K |
| 249 | HELP | Cybin Inc. | 384.76M | 2.12% | 227,656 | - |
| 250 | ENTA | Enanta Pharmaceuticals, Inc. | 369.44M | 1.83% | 260,366 | 65.32M |
| 251 | AURA | Aura Biosciences, Inc. | 364.51M | 4.74% | 250,952 | - |
| 252 | FHTX | Foghorn Therapeutics Inc. | 363.21M | 1.97% | 298,419 | 24.52M |
| 253 | ACIU | AC Immune SA | 359.16M | 6.76% | 423,837 | 5.48M |
| 254 | NMRA | Neumora Therapeutics, Inc. | 356.87M | 7.69% | 1,343,764 | - |
| 255 | TECX | Tectonic Therapeutic, Inc. | 356.36M | 1.06% | 158,944 | - |
| 256 | CADL | Candel Therapeutics, Inc. | 345.86M | - | 846,410 | - |
| 257 | PBYI | Puma Biotechnology, Inc. | 345.68M | -0.44% | 766,862 | 212.00M |
| 258 | IMRX | Immuneering Corporation | 344.80M | 10.10% | 2,068,476 | - |
| 259 | XOMA | XOMA Royalty Corporation | 333.35M | -1.28% | 806,508 | 47.11M |
| 260 | XFOR | X4 Pharmaceuticals, Inc. | 328.76M | 0.27% | 354,631 | 33.98M |
| 261 | AARD | Aardvark Therapeutics, Inc. | 328.34M | -4.68% | 266,062 | - |
| 262 | GLSI | Greenwich LifeSciences, Inc. | 326.41M | 5.65% | 4,908,247 | - |
| 263 | GUTS | Fractyl Health, Inc. | 317.48M | 11.89% | 4,069,034 | 3.00K |
| 264 | TARA | Protara Therapeutics, Inc. | 316.70M | 2.43% | 556,103 | - |
| 265 | ALDX | Aldeyra Therapeutics, Inc. | 314.05M | 4.61% | 957,271 | - |
| 266 | CLLS | Cellectis S.A. | 310.17M | 6.33% | 44,116 | 82.55M |
| 267 | RZLT | Rezolute, Inc. | 303.22M | 8.28% | 2,907,735 | - |
| 268 | AVTX | Avalo Therapeutics, Inc. | 300.83M | 3.11% | 290,289 | 192.00K |
| 269 | OABI | OmniAb, Inc. | 297.27M | 2.74% | 213,923 | 21.09M |
| 270 | LRMR | Larimar Therapeutics, Inc. | 295.29M | 3.92% | 999,748 | - |
| 271 | ACHV | Achieve Life Sciences, Inc. | 293.85M | 1.85% | 543,233 | - |
| 272 | NGNE | Neurogene Inc. | 292.29M | 3.06% | 90,499 | 925.00K |
| 273 | ABEO | Abeona Therapeutics Inc. | 290.47M | 0.94% | 1,363,756 | 400.00K |
| 274 | RLMD | Relmada Therapeutics, Inc. | 290.40M | 3.94% | 434,800 | - |
| 275 | NAUT | Nautilus Biotechnology, Inc. | 287.34M | 4.36% | 139,263 | - |
| 276 | AVIR | Atea Pharmaceuticals, Inc. | 285.94M | 3.98% | 361,442 | - |
| 277 | CABA | Cabaletta Bio, Inc. | 283.02M | 25.64% | 29,802,516 | - |
| 278 | IMMX | Immix Biopharma, Inc. | 276.65M | 7.36% | 1,197,528 | - |
| 279 | STTK | Shattuck Labs, Inc. | 275.90M | -1.80% | 211,204 | 1.00M |
| 280 | PALI | Palisade Bio, Inc. | 275.66M | 5.71% | 5,495,280 | - |
| 281 | SLN | Silence Therapeutics plc | 274.90M | 2.46% | 269,108 | 25.83M |
| 282 | CBIO | Crescent Biopharma, Inc. | 266.46M | -0.66% | 148,405 | - |
| 283 | FENC | Fennec Pharmaceuticals Inc. | 266.40M | 1.30% | 45,052 | 38.79M |
| 284 | HRTX | Heron Therapeutics, Inc. | 265.88M | -0.68% | 941,478 | 155.10M |
| 285 | ENLV | Enlivex Therapeutics Ltd. | 249.25M | 7.03% | 588,954 | - |
| 286 | IKT | Inhibikase Therapeutics, Inc. | 246.62M | 3.03% | 459,018 | 1.00 |
| 287 | CAMP | Camp4 Therapeutics Corporation | 245.40M | 5.11% | 128,100 | 3.80M |
| 288 | MENS | Jyong Biotech Ltd. | 243.77M | -0.63% | 396,366 | - |
| 289 | TNXP | Tonix Pharmaceuticals Holding Corp. | 235.56M | 4.62% | 540,662 | 10.30M |
| 290 | CLYM | Climb Bio, Inc. | 234.43M | 14.45% | 1,359,925 | - |
| 291 | OBIO | Orchestra BioMed Holdings, Inc. | 233.20M | 0.98% | 78,177 | 2.82M |
| 292 | EDIT | Editas Medicine, Inc. | 232.33M | 12.26% | 3,541,401 | 46.38M |
| 293 | VYGR | Voyager Therapeutics, Inc. | 227.96M | 8.75% | 843,735 | 31.32M |
| 294 | OVID | Ovid Therapeutics Inc. | 227.82M | 6.71% | 2,431,266 | 6.61M |
| 295 | GALT | Galectin Therapeutics Inc. | 227.59M | 11.36% | 286,119 | - |
| 296 | ARMP | Armata Pharmaceuticals, Inc. | 225.36M | 3.51% | 19,307 | 5.05M |
| 297 | MDWD | MediWound Ltd. | 224.38M | 2.52% | 106,726 | 20.93M |
| 298 | NVCT | Nuvectis Pharma, Inc. | 224.13M | 1.98% | 51,838 | - |
| 299 | HUMA | Humacyte, Inc. | 216.16M | 14.29% | 9,091,797 | 1.57M |
| 300 | ARCT | Arcturus Therapeutics Holdings Inc. | 215.66M | 4.40% | 634,673 | 97.60M |
| 301 | CCCC | C4 Therapeutics, Inc. | 211.27M | 2.83% | 779,548 | 30.11M |
| 302 | ZNTL | Zentalis Pharmaceuticals, Inc. | 210.44M | 10.17% | 1,049,815 | 26.87M |
| 303 | ALEC | Alector, Inc. | 209.57M | - | 516,414 | 69.05M |
| 304 | TLSA | Tiziana Life Sciences Ltd | 207.87M | -2.92% | 266,207 | - |
| 305 | SGMT | Sagimet Biosciences Inc. | 206.51M | - | 349,939 | - |
| 306 | MIST | Milestone Pharmaceuticals Inc. | 202.15M | -1.00% | 2,276,726 | - |
| 307 | IPSC | Century Therapeutics, Inc. | 201.69M | 13.24% | 1,738,219 | 113.34M |
| 308 | CGEN | Compugen Ltd. | 200.17M | 1.42% | 212,289 | 6.90M |
| 309 | CRDF | Cardiff Oncology, Inc. | 200.06M | 2.77% | 639,368 | 501.00K |
| 310 | RNAC | Cartesian Therapeutics, Inc. | 197.37M | -0.65% | 67,779 | 1.09M |
| 311 | CHRS | Coherus Oncology, Inc. | 192.18M | -3.05% | 2,745,746 | 277.73M |
| 312 | SABS | SAB Biotherapeutics, Inc. | 190.43M | -0.74% | 289,048 | 114.70K |
| 313 | PRLD | Prelude Therapeutics Incorporated | 183.75M | 22.53% | 651,062 | 10.50M |
| 314 | KLRS | Kalaris Therapeutics, Inc. | 183.28M | 0.10% | 32,473 | - |
| 315 | QNCX | Quince Therapeutics, Inc. | 180.41M | -0.31% | 777,933 | - |
| 316 | PRQR | ProQR Therapeutics N.V. | 180.14M | 4.27% | 328,315 | 18.86M |
| 317 | ELDN | Eledon Pharmaceuticals, Inc. | 176.96M | 1.36% | 541,221 | - |
| 318 | IRD | Opus Genetics, Inc. | 172.41M | 5.93% | 614,431 | 14.63M |
| 319 | SRZN | Surrozen, Inc. | 171.39M | 4.30% | 160,233 | 3.60M |
| 320 | NKTX | Nkarta, Inc. | 170.47M | 9.09% | 1,637,819 | - |
| 321 | NERV | Minerva Neurosciences, Inc. | 170.07M | -6.21% | 157,700 | - |
| 322 | RANI | Rani Therapeutics Holdings, Inc. | 168.91M | 2.96% | 1,410,898 | 1.20M |
| 323 | PLX | Protalix BioTherapeutics, Inc. | 168.08M | 0.97% | 494,629 | 61.84M |
| 324 | NTHI | NeOnc Technologies Holdings, Inc. | 166.70M | 6.20% | 40,842 | 59.99K |
| 325 | CDXS | Codexis, Inc. | 165.75M | 7.31% | 773,706 | 52.93M |
| 326 | CNTX | Context Therapeutics Inc. | 164.46M | 9.15% | 1,851,345 | - |
| 327 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 164.16M | 2.31% | 111,093 | - |
| 328 | TNYA | Tenaya Therapeutics, Inc. | 163.22M | 5.31% | 3,663,369 | - |
| 329 | IPHA | Innate Pharma S.A. | 162.41M | 2.87% | 20,726 | 14.84M |
| 330 | SLGL | Sol-Gel Technologies Ltd. | 160.18M | -8.74% | 22,972 | 18.97M |
| 331 | VXRT | Vaxart, Inc. | 158.39M | - | - | 148.20M |
| 332 | UNCY | Unicycive Therapeutics, Inc. | 153.23M | 8.03% | 825,180 | - |
| 333 | CRBU | Caribou Biosciences, Inc. | 151.42M | 8.72% | 1,078,298 | 9.30M |
| 334 | BDTX | Black Diamond Therapeutics, Inc. | 150.98M | 3.11% | 572,639 | 70.00M |
| 335 | CNTB | Connect Biopharma Holdings Limited | 148.70M | 6.40% | 201,047 | 762.00K |
| 336 | MOLN | Molecular Partners AG | 147.86M | -0.85% | 5,379 | 856.30K |
| 337 | FATE | Fate Therapeutics, Inc. | 144.19M | 5.93% | 2,715,650 | 7.14M |
| 338 | ELTX | Elicio Therapeutics, Inc. | 139.98M | 1.52% | 76,684 | - |
| 339 | TTRX | Turn Therapeutics Inc. | 139.28M | 1.94% | 33,067 | - |
| 340 | STRO | Sutro Biopharma, Inc. | 139.04M | 3.29% | 131,764 | 105.65M |
| 341 | MCRB | Seres Therapeutics, Inc. | 138.68M | 1.86% | 38,087 | 351.00K |
| 342 | SPRO | Spero Therapeutics, Inc. | 138.03M | 3.81% | 299,595 | 40.55M |
| 343 | ONCY | Oncolytics Biotech Inc. | 136.66M | 8.55% | 3,055,412 | - |
| 344 | WHWK | Whitehawk Therapeutics, Inc. | 134.32M | 2.52% | 123,933 | 14.38M |
| 345 | SGMO | Sangamo Therapeutics, Inc. | 134.09M | 4.79% | 3,709,791 | 32.88M |
| 346 | ORMP | Oramed Pharmaceuticals Inc. | 132.14M | -3.49% | 280,654 | 2.00M |
| 347 | CGTX | Cognition Therapeutics, Inc. | 128.88M | 2.82% | 721,614 | - |
| 348 | ACTU | Actuate Therapeutics, Inc. | 127.84M | -6.14% | 87,201 | - |
| 349 | GNLX | Genelux Corporation | 127.54M | 1.77% | 352,074 | 8.00K |
| 350 | ACOG | Alpha Cognition Inc. | 123.93M | -2.56% | 32,192 | 7.43M |
| 351 | VRCA | Verrica Pharmaceuticals Inc. | 123.52M | -0.45% | 36,220 | 30.83M |
| 352 | KPTI | Karyopharm Therapeutics Inc. | 121.58M | 5.06% | 358,072 | 142.53M |
| 353 | ARTV | Artiva Biotherapeutics, Inc. | 121.50M | 4.21% | 207,375 | 251.00K |
| 354 | ABOS | Acumen Pharmaceuticals, Inc. | 120.54M | 9.94% | 239,053 | - |
| 355 | THAR | Tharimmune, Inc. | 118.98M | 7.89% | 485,936 | - |
| 356 | AGEN | Agenus Inc. | 114.95M | -0.59% | 460,541 | 106.83M |
| 357 | SAVA | Cassava Sciences, Inc. | 112.07M | 6.91% | 1,688,196 | - |
| 358 | MGNX | MacroGenics, Inc. | 111.97M | 1.72% | 2,945,002 | 127.63M |
| 359 | RPTX | Repare Therapeutics Inc. | 111.65M | - | 1,001,209 | 11.87M |
| 360 | ANIX | Anixa Biosciences, Inc. | 110.14M | 4.10% | 205,234 | - |
| 361 | SEER | Seer, Inc. | 109.13M | 3.19% | 174,407 | 16.38M |
| 362 | FBIO | Fortress Biotech, Inc. | 108.01M | 0.58% | 438,694 | 62.30M |
| 363 | HYFT | MindWalk Holdings Corp. | 107.39M | 13.30% | 784,860 | 19.02M |
| 364 | VANI | Vivani Medical, Inc. | 107.24M | -2.65% | 581,970 | - |
| 365 | INO | Inovio Pharmaceuticals, Inc. | 107.18M | 3.31% | 632,079 | 182.34K |
| 366 | PYXS | Pyxis Oncology, Inc. | 106.47M | 3.01% | 430,714 | 2.82M |
| 367 | DTIL | Precision BioSciences, Inc. | 102.30M | 5.99% | 319,619 | 698.00K |
| 368 | BMEA | Biomea Fusion, Inc. | 101.81M | 2.13% | 738,340 | - |
| 369 | ETHZ | ETHZilla Corporation | 100.19M | 4.15% | 359,318 | 4.11M |
| 370 | KRRO | Korro Bio, Inc. | 98.98M | 10.98% | 317,869 | 7.37M |
| 371 | COYA | Coya Therapeutics, Inc. | 98.97M | 3.96% | 212,574 | 3.99M |
| 372 | DWTX | Dogwood Therapeutics, Inc. | 98.49M | 7.72% | 32,014 | - |
| 373 | EXOZ | eXoZymes, Inc. | 97.02M | -0.43% | 387 | -700.00 |
| 374 | ADAG | Adagene Inc. | 95.68M | 20.12% | 599,628 | 103.20K |
| 375 | CSBR | Champions Oncology, Inc. | 95.12M | -3.39% | 4,093 | 58.42M |
| 376 | MAIA | MAIA Biotechnology, Inc. | 91.84M | 2.56% | 1,177,110 | - |
| 377 | SPRB | Spruce Biosciences, Inc. | 91.24M | 8.01% | 57,687 | 697.00K |
| 378 | OKYO | OKYO Pharma Limited | 89.14M | 13.94% | 202,591 | - |
| 379 | CBUS | Cibus, Inc. | 86.21M | 5.30% | 307,453 | 3.79M |
| 380 | ACET | Adicet Bio, Inc. | 84.89M | 4.09% | 240,591 | - |
| 381 | MREO | Mereo BioPharma Group plc | 84.69M | 0.42% | 9,503,022 | 500.00K |
| 382 | ATOS | Atossa Therapeutics, Inc. | 84.56M | 8.50% | 1,137,485 | - |
| 383 | IMUX | Immunic, Inc. | 82.80M | 4.41% | 1,181,668 | - |
| 384 | COEP | Coeptis Therapeutics Holdings, Inc. | 82.45M | 9.22% | 51,573 | 501.00K |
| 385 | MNOV | MediciNova, Inc. | 81.58M | -1.19% | 91,146 | 257.92K |
| 386 | ANVS | Annovis Bio, Inc. | 81.10M | 6.25% | 721,596 | - |
| 387 | XBIT | XBiotech Inc. | 80.18M | 3.14% | 60,661 | - |
| 388 | GANX | Gain Therapeutics, Inc. | 80.00M | 5.58% | 698,711 | - |
| 389 | PLRX | Pliant Therapeutics, Inc. | 79.88M | 3.17% | 974,418 | - |
| 390 | PYPD | PolyPid Ltd. | 79.85M | 4.58% | 171,108 | - |
| 391 | ALXO | ALX Oncology Holdings Inc. | 79.70M | - | 252,842 | - |
| 392 | CALC | CalciMedica, Inc. | 76.95M | -4.13% | 44,699 | - |
| 393 | KZIA | Kazia Therapeutics Limited | 76.27M | -1.13% | 190,230 | 1.20M |
| 394 | IMA | ImageneBio, Inc. | 75.30M | -0.42% | 19,810 | 800.00K |
| 395 | ANL | Adlai Nortye Ltd. | 75.28M | 10.27% | 82,684 | -1.35M |
| 396 | PTHS | Pelthos Therapeutics Inc. | 75.16M | 5.73% | 11,259 | 7.41M |
| 397 | TVGN | Tevogen Bio Holdings Inc. | 73.64M | 9.46% | 362,013 | - |
| 398 | ATYR | aTyr Pharma, Inc. | 73.14M | 5.22% | 1,175,564 | 190.00K |
| 399 | ENTX | Entera Bio Ltd. | 72.45M | - | 153,384 | 124.00K |
| 400 | EQ | Equillium, Inc. | 71.85M | 6.31% | 383,720 | 4.39M |
| 401 | IFRX | InflaRx N.V. | 69.78M | 3.00% | 441,380 | 73.73K |
| 402 | NRXP | NRx Pharmaceuticals, Inc. | 69.28M | 3.54% | 612,424 | 242.00K |
| 403 | BYSI | BeyondSpring Inc. | 68.67M | - | 29,880 | 1.88M |
| 404 | TCRX | TScan Therapeutics, Inc. | 66.96M | 3.51% | 382,823 | 8.42M |
| 405 | MGX | Metagenomi Therapeutics, Inc. | 65.89M | 7.67% | 515,050 | 30.91M |
| 406 | ACRV | Acrivon Therapeutics, Inc. | 64.06M | -2.87% | 1,160,449 | - |
| 407 | PMVP | PMV Pharmaceuticals, Inc. | 60.66M | 7.55% | 411,902 | - |
| 408 | CRVO | CervoMed Inc. | 60.61M | -1.36% | 67,710 | 6.16M |
| 409 | ICCC | ImmuCell Corporation | 59.34M | -3.53% | 10,233 | 27.77M |
| 410 | ATHE | Alterity Therapeutics Limited | 58.84M | 0.62% | 7,014 | 3.57M |
| 411 | GRCE | Grace Therapeutics, Inc. | 58.80M | 3.54% | 146,086 | - |
| 412 | LPCN | Lipocine Inc. | 57.91M | 7.64% | 116,916 | 4.32M |
| 413 | INKT | MiNK Therapeutics, Inc. | 57.60M | -0.08% | 8,884 | - |
| 414 | NTRB | Nutriband Inc. | 55.38M | 2.37% | 19,383 | 2.28M |
| 415 | RADX | Radiopharm Theranostics Limited | 55.13M | 3.48% | 25,851 | 8.20M |
| 416 | CVM | CEL-SCI Corporation | 53.90M | 21.86% | 127,388 | - |
| 417 | IBIO | iBio, Inc. | 53.74M | 6.70% | 1,773,087 | 500.00K |
| 418 | PDSB | PDS Biotechnology Corporation | 53.02M | 4.03% | 1,227,665 | - |
| 419 | ALGS | Aligos Therapeutics, Inc. | 52.55M | 6.75% | 123,682 | 2.65M |
| 420 | OSTX | OS Therapies Incorporated | 51.77M | -2.00% | 640,778 | - |
| 421 | QTTB | Q32 Bio Inc. | 50.45M | -1.91% | 114,914 | - |
| 422 | PSTV | Plus Therapeutics, Inc. | 50.42M | -2.33% | 57,676,448 | 5.26M |
| 423 | IBO | Impact BioMedical Inc. | 50.11M | -4.21% | 43,857 | 25.00K |
| 424 | NRXS | NeurAxis, Inc. | 49.32M | -5.70% | 136,115 | 3.36M |
| 425 | ABVC | ABVC BioPharma, Inc. | 48.56M | 0.49% | 50,801 | 797.92K |
| 426 | LITS | Lite Strategy, Inc. | 48.54M | - | 445,652 | - |
| 427 | TIL | Instil Bio, Inc. | 47.88M | -0.28% | 101,783 | - |
| 428 | GLTO | Galecto, Inc. | 47.25M | 5.01% | 37,142 | - |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 46.07M | 1.52% | 84,639 | - |
| 430 | TVRD | Tvardi Therapeutics, Inc. | 45.31M | 2.77% | 37,878 | - |
| 431 | INMB | INmune Bio Inc. | 45.19M | 3.66% | 444,447 | 50.00K |
| 432 | ANEB | Anebulo Pharmaceuticals, Inc. | 45.19M | 0.92% | 22,318 | - |
| 433 | KZR | Kezar Life Sciences, Inc. | 45.04M | -0.65% | 47,924 | - |
| 434 | NXTC | NextCure, Inc. | 44.45M | -2.39% | 28,270 | - |
| 435 | JSPR | Jasper Therapeutics, Inc. | 43.93M | 3.29% | 555,963 | - |
| 436 | VERU | Veru Inc. | 43.22M | 3.98% | 173,663 | 16.89M |
| 437 | ATNM | Actinium Pharmaceuticals, Inc. | 41.80M | 1.52% | 106,661 | 90.00K |
| 438 | XLO | Xilio Therapeutics, Inc. | 41.70M | 3.40% | 1,710,146 | 31.80M |
| 439 | HURA | TuHURA Biosciences, Inc. | 41.25M | -1.11% | 334,864 | - |
| 440 | OKUR | OnKure Therapeutics, Inc. | 41.19M | 6.29% | 70,592 | - |
| 441 | XCUR | Exicure, Inc. | 40.98M | 2.39% | 57,216 | 500.00K |
| 442 | PASG | Passage Bio, Inc. | 40.37M | 3.08% | 71,333 | - |
| 443 | APLM | Apollomics, Inc. | 40.11M | -3.49% | 9,522 | 6.93M |
| 444 | ESLA | Estrella Immunopharma, Inc. | 39.67M | 3.37% | 36,205 | - |
| 445 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 39.33M | 2.94% | 3,187,812 | - |
| 446 | CING | Cingulate Inc. | 38.58M | -2.89% | 327,492 | - |
| 447 | GBIO | Generation Bio Co. | 38.40M | 4.21% | 411,442 | 15.27M |
| 448 | LTRN | Lantern Pharma Inc. | 38.36M | 1.18% | 46,868 | - |
| 449 | CELU | Celularity Inc. | 36.77M | 2.00% | 66,621 | 40.58M |
| 450 | RNXT | RenovoRx, Inc. | 36.65M | 0.24% | 325,741 | 928.00K |
| 451 | KYNB | Kyntra Bio, Inc. | 36.09M | 2.06% | 16,778 | 8.30M |
| 452 | ATRA | Atara Biotherapeutics, Inc. | 36.05M | 8.70% | 569,610 | 151.93M |
| 453 | LSTA | Lisata Therapeutics, Inc. | 35.81M | 0.74% | 366,793 | 1.07M |
| 454 | RNTX | Rein Therapeutics Inc. | 35.22M | 10.74% | 185,430 | - |
| 455 | EVAX | Evaxion A/S | 34.95M | 0.24% | 65,605 | 7.65M |
| 456 | IOBT | IO Biotech, Inc. | 34.54M | 131.26% | 470,371,701 | - |
| 457 | MRKR | Marker Therapeutics, Inc. | 34.01M | -6.85% | 866,276 | 4.69M |
| 458 | HOWL | Werewolf Therapeutics, Inc. | 33.82M | 16.51% | 979,669 | 1.14M |
| 459 | DYAI | Dyadic International, Inc. | 33.51M | 4.26% | 20,396 | 3.34M |
| 460 | SKYE | Skye Bioscience, Inc. | 33.50M | 6.57% | 234,941 | - |
| 461 | CUE | Cue Biopharma, Inc. | 33.28M | -2.90% | 6,231,195 | 7.10M |
| 462 | ANTX | AN2 Therapeutics, Inc. | 33.16M | 2.54% | 224,772 | - |
| 463 | PLUR | Pluri Inc. | 32.83M | 9.30% | 23,513 | 1.33M |
| 464 | OTLK | Outlook Therapeutics, Inc. | 32.70M | 0.79% | 1,800,518 | 1.41M |
| 465 | JUNS | Jupiter Neurosciences, Inc. | 32.19M | 0.59% | 109,814 | - |
| 466 | SER | Serina Therapeutics, Inc. | 31.57M | 3.86% | 28,214 | 116.00K |
| 467 | GNTA | Genenta Science S.p.A. | 31.40M | 1.52% | 26,541 | - |
| 468 | SNTI | Senti Biosciences, Inc. | 30.50M | 7.41% | 699,315 | - |
| 469 | PTN | Palatin Technologies, Inc. | 29.89M | 2.39% | 36,007 | 8.85M |
| 470 | BRNS | Barinthus Biotherapeutics plc | 29.72M | 2.54% | 21,563 | 14.97M |
| 471 | LIXT | Lixte Biotechnology Holdings, Inc. | 29.19M | 6.01% | 29,330 | - |
| 472 | IGC | IGC Pharma, Inc. | 28.85M | 7.31% | 808,000 | 1.11M |
| 473 | BOLD | Boundless Bio, Inc. | 28.43M | 2.42% | 122,724 | - |
| 474 | RLYB | Rallybio Corporation | 28.41M | -1.67% | 162,716 | 674.00K |
| 475 | DARE | Daré Bioscience, Inc. | 28.15M | 1.55% | 49,248 | -57.13K |
| 476 | NRSN | NeuroSense Therapeutics Ltd. | 27.92M | -2.79% | 325,453 | - |
| 477 | VTGN | Vistagen Therapeutics, Inc. | 26.17M | 4.49% | 1,372,904 | 721.00K |
| 478 | KLTO | Klotho Neurosciences, Inc. | 25.08M | 3.33% | 904,550 | - |
| 479 | QNTM | Quantum BioPharma Ltd. | 24.99M | -1.87% | 69,497 | - |
| 480 | PLRZ | Polyrizon Ltd. | 24.98M | -2.00% | 127,432 | - |
| 481 | NNVC | NanoViricides, Inc. | 24.80M | -2.54% | 196,738 | - |
| 482 | HYPD | Hyperion DeFi, Inc. | 24.61M | 3.18% | 176,195 | 345.32K |
| 483 | INTS | Intensity Therapeutics, Inc. | 24.28M | 1.84% | 967,034 | - |
| 484 | LONA | LeonaBio, Inc. | 24.25M | -1.76% | 33,237 | - |
| 485 | INAB | IN8bio, Inc. | 24.22M | 6.44% | 30,990 | - |
| 486 | FBLG | FibroBiologics, Inc. | 22.62M | 4.13% | 874,504 | - |
| 487 | NEUP | Neuphoria Therapeutics Inc. | 22.42M | 3.22% | 45,994 | 15.65M |
| 488 | ALLR | Allarity Therapeutics, Inc. | 21.53M | 5.08% | 87,067 | - |
| 489 | LNAI | Lunai Bioworks Inc. | 21.51M | 9.27% | 114,246 | - |
| 490 | CLGN | CollPlant Biotechnologies Ltd. | 21.21M | 17.73% | 31,828 | 2.48M |
| 491 | KTTA | Pasithea Therapeutics Corp. | 20.98M | -0.13% | 111,728 | - |
| 492 | LIMN | Liminatus Pharma, Inc. | 20.84M | 7.62% | 70,888 | - |
| 493 | LEXX | Lexaria Bioscience Corp. | 20.34M | 2.14% | 319,971 | 522.00K |
| 494 | BCAB | BioAtla, Inc. | 20.32M | 6.73% | 1,221,818 | 11.00M |
| 495 | CASI | CASI Pharmaceuticals, Inc. | 20.29M | -1.24% | 31,235 | 26.85M |
| 496 | PMN | ProMIS Neurosciences, Inc. | 19.91M | 12.10% | 45,032 | - |
| 497 | TRAW | Traws Pharma, Inc. | 19.90M | 2.47% | 208,801 | 2.85M |
| 498 | OSRH | OSR Holdings, Inc. | 19.67M | 10.23% | 1,612,250 | -90.52K |
| 499 | VYNE | VYNE Therapeutics Inc. | 19.31M | 0.05% | 746,257 | 524.00K |
| 500 | ITRM | Iterum Therapeutics plc | 18.50M | 10.44% | 394,742 | 390.00K |
| 501 | CVKD | Cadrenal Therapeutics, Inc. | 17.89M | 7.59% | 21,589 | - |
| 502 | CTXR | Citius Pharmaceuticals, Inc. | 17.64M | 6.19% | 253,988 | - |
| 503 | KALA | KALA BIO, Inc. | 16.67M | -2.09% | 804,793 | - |
| 504 | HOTH | Hoth Therapeutics, Inc. | 16.29M | - | 2,534,526 | - |
| 505 | KAPA | Kairos Pharma, Ltd. | 16.24M | -8.24% | 541,015 | - |
| 506 | APLT | Applied Therapeutics, Inc. | 16.16M | 4.54% | 7,620,011 | 1.00M |
| 507 | CLRB | Cellectar Biosciences, Inc. | 16.15M | 4.38% | 46,623 | - |
| 508 | TPST | Tempest Therapeutics, Inc. | 15.13M | 17.62% | 392,300 | - |
| 509 | MBRX | Moleculin Biotech, Inc. | 14.69M | 0.21% | 191,470 | - |
| 510 | COCP | Cocrystal Pharma, Inc. | 14.61M | 1.92% | 90,496 | - |
| 511 | SNGX | Soligenix, Inc. | 14.32M | 1.43% | 192,489 | 2.34K |
| 512 | SNSE | Sensei Biotherapeutics, Inc. | 14.29M | 20.40% | 184,836 | - |
| 513 | BCDA | BioCardia, Inc. | 13.90M | 2.34% | 79,133 | 3.00K |
| 514 | AEON | AEON Biopharma, Inc. | 13.85M | -13.97% | 1,851,019 | - |
| 515 | NCNA | NuCana plc | 13.40M | -0.92% | 42,508 | - |
| 516 | BLRX | BioLineRx Ltd. | 12.42M | 3.97% | 6,920 | 12.74M |
| 517 | AKTX | Akari Therapeutics, Plc | 12.29M | 2.87% | 500,445 | - |
| 518 | NCEL | NewcelX Ltd. | 12.13M | 9.92% | 115,879 | - |
| 519 | BOLT | Bolt Biotherapeutics, Inc. | 12.09M | 0.48% | 7,073 | 5.20M |
| 520 | EDSA | Edesa Biotech, Inc. | 12.08M | 0.69% | 40,449 | - |
| 521 | IMNN | Imunon, Inc. | 11.97M | 1.15% | 26,537 | - |
| 522 | GRDX | GridAI Technologies Corp. | 11.87M | 6.01% | 135,454 | - |
| 523 | LGVN | Longeveron Inc. | 11.71M | 2.95% | 60,647 | 1.44M |
| 524 | PHIO | Phio Pharmaceuticals Corp. | 11.68M | 4.33% | 305,866 | - |
| 525 | CRIS | Curis, Inc. | 11.61M | 0.32% | 296,619 | 11.65M |
| 526 | GDTC | CytoMed Therapeutics Limited | 10.96M | -10.27% | 26,133 | 573.19K |
| 527 | CMMB | Chemomab Therapeutics Ltd. | 10.53M | -0.58% | 87,454 | - |
| 528 | BRTX | BioRestorative Therapies, Inc. | 10.25M | 0.43% | 14,932 | 383.40K |
| 529 | PULM | Pulmatrix, Inc. | 9.79M | 1.90% | 8,543 | 3.00K |
| 530 | ERNA | Ernexa Therapeutics Inc. | 9.73M | 5.08% | 64,425 | 1,000.00 |
| 531 | BIVI | BioVie Inc. | 9.42M | 4.17% | 118,118 | - |
| 532 | ICU | SeaStar Medical Holding Corporation | 9.34M | 14.10% | 216,371 | 881.00K |
| 533 | PMCB | PharmaCyte Biotech, Inc. | 9.11M | 2.74% | 87,271 | - |
| 534 | APVO | Aptevo Therapeutics Inc. | 9.08M | -2.05% | 64,681 | - |
| 535 | MTVA | MetaVia Inc. | 8.95M | -3.12% | 228,672 | - |
| 536 | XTLB | XTL Biopharmaceuticals Ltd. | 8.75M | 8.11% | 268,476 | 968.00K |
| 537 | EVGN | Evogene Ltd. | 8.70M | 1.47% | 8,641 | 8.02M |
| 538 | ALZN | Alzamend Neuro, Inc. | 8.67M | -6.17% | 520,248 | - |
| 539 | RNAZ | TransCode Therapeutics, Inc. | 8.55M | -0.64% | 11,668 | - |
| 540 | IMRN | Immuron Limited | 8.23M | 1.42% | 21,496 | 4.78M |
| 541 | QNRX | Quoin Pharmaceuticals, Ltd. | 8.10M | -3.11% | 27,126 | - |
| 542 | KPRX | Kiora Pharmaceuticals, Inc. | 8.07M | 0.92% | 28,316 | 20.00K |
| 543 | APM | Aptorum Group Limited | 8.02M | 0.43% | 30,710 | - |
| 544 | BCTX | BriaCell Therapeutics Corp. | 7.95M | 4.75% | 384,700 | - |
| 545 | ADXN | Addex Therapeutics Ltd | 7.93M | -3.61% | 3,368 | 198.82K |
| 546 | ABP | Abpro Holdings, Inc. | 7.89M | -11.20% | 40,082 | 183.00K |
| 547 | CELZ | Creative Medical Technology Holdings, Inc. | 7.86M | 15.38% | 76,527 | 6.00K |
| 548 | MBIO | Mustang Bio, Inc. | 7.81M | 7.00% | 71,782 | - |
| 549 | GTBP | GT Biopharma, Inc. | 7.66M | 1.41% | 671,646 | - |
| 550 | CLDI | Calidi Biotherapeutics, Inc. | 7.61M | 4.00% | 70,332 | - |
| 551 | TOVX | Theriva Biologics, Inc. | 7.38M | 7.82% | 1,700,603 | - |
| 552 | PCSA | Processa Pharmaceuticals, Inc. | 7.27M | 2.56% | 54,847 | - |
| 553 | SLXN | Silexion Therapeutics Corp | 6.85M | 3.83% | 7,980 | - |
| 554 | BGMS | Bio Green Med Solution, Inc. | 6.81M | -0.71% | 24,458 | 81.00K |
| 555 | GNPX | Genprex, Inc. | 6.79M | 3.53% | 524,465 | - |
| 556 | ACXP | Acurx Pharmaceuticals, Inc. | 6.53M | 9.45% | 55,726 | - |
| 557 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 6.49M | 152.00% | 194,784,571 | 1.36M |
| 558 | PPBT | Purple Biotech Ltd | 6.48M | 7.20% | 104,442 | - |
| 559 | TCRT | Alaunos Therapeutics, Inc. | 6.45M | -3.67% | 17,911 | 6.00K |
| 560 | ADIL | Adial Pharmaceuticals, Inc. | 6.39M | 5.80% | 215,232 | - |
| 561 | INDP | Indaptus Therapeutics, Inc. | 6.38M | 7.36% | 27,491 | - |
| 562 | XBIO | Xenetic Biosciences, Inc. | 5.96M | 7.44% | 41,647 | 2.86M |
| 563 | APRE | Aprea Therapeutics, Inc. | 5.89M | 1.19% | 98,137 | 488.24K |
| 564 | CANF | Can-Fite BioPharma Ltd. | 5.46M | 1.96% | 95,091 | 560.00K |
| 565 | PHGE | BiomX Inc. | 5.45M | 16.67% | 136,323 | - |
| 566 | CYCN | Cyclerion Therapeutics, Inc. | 5.25M | 2.22% | 55,748 | 2.86M |
| 567 | VIVS | VivoSim Labs, Inc. | 5.23M | 0.75% | 9,685 | 140.00K |
| 568 | REVB | Revelation Biosciences, Inc. | 5.06M | 1.71% | 8,000,744 | - |
| 569 | GOVX | GeoVax Labs, Inc. | 4.95M | -3.36% | 446,247 | 3.35M |
| 570 | SILO | Silo Pharma, Inc. | 4.91M | 3.57% | 45,798 | 72.10K |
| 571 | ASBP | Aspire Biopharma Holdings, Inc. | 4.86M | -5.24% | 1,508,030 | 1.94K |
| 572 | DCOY | Decoy Therapeutics Inc. | 4.79M | 5.26% | 303,100 | - |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 4.67M | 4.68% | 72,470 | - |
| 574 | SPRC | SciSparc Ltd. | 4.39M | -3.81% | 319,627 | 1.31M |
| 575 | ENVB | Enveric Biosciences, Inc. | 4.36M | 2.16% | 31,275 | - |
| 576 | ELAB | PMGC Holdings Inc. | 4.30M | 7.40% | 185,327 | 285.95K |
| 577 | CMND | Clearmind Medicine Inc. | 4.05M | 5.47% | 80,258 | - |
| 578 | LYRA | Lyra Therapeutics, Inc. | 3.90M | -2.22% | 43,360 | 600.00K |
| 579 | XRTX | XORTX Therapeutics Inc. | 3.88M | -4.01% | 16,203 | - |
| 580 | CNSP | CNS Pharmaceuticals, Inc. | 3.88M | -6.99% | 36,086 | - |
| 581 | OGEN | Oragenics, Inc. | 3.87M | -6.32% | 16,394,375 | - |
| 582 | MTNB | Matinas BioPharma Holdings, Inc. | 3.78M | - | 12,702 | - |
| 583 | HCWB | HCW Biologics Inc. | 3.76M | 4.51% | 111,799 | 422.03K |
| 584 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.62M | 7.61% | 105,022 | 15.78K |
| 585 | PPCB | Propanc Biopharma, Inc. | 3.55M | -1.77% | 219,710 | - |
| 586 | ARTL | Artelo Biosciences, Inc. | 3.49M | 1.17% | 47,721 | - |
| 587 | JAGX | Jaguar Health, Inc. | 3.31M | -9.78% | 6,056,481 | 11.79M |
| 588 | ENSC | Ensysce Biosciences, Inc. | 3.23M | -3.20% | 91,469 | 4.49M |
| 589 | BBLG | Bone Biologics Corporation | 3.11M | 0.58% | 34,737 | - |
| 590 | AZTR | Azitra, Inc. | 3.05M | -0.63% | 1,277,437 | 7.50K |
| 591 | SCNI | Scinai Immunotherapeutics Ltd. | 2.90M | -1.39% | 3,069 | 1.15M |
| 592 | DRMA | Dermata Therapeutics, Inc. | 2.83M | 15.87% | 403,892 | - |
| 593 | GRI | GRI Bio, Inc. | 2.73M | -12.02% | 3,974,416 | - |
| 594 | ONCO | Onconetix, Inc. | 2.53M | 1.87% | 1,107,292 | 1.22M |
| 595 | CDT | CDT Equity Inc. | 2.43M | -2.78% | 1,672,976 | - |
| 596 | ADTX | Aditxt, Inc. | 2.08M | -19.86% | 2,246,782 | 5.95K |
| 597 | VRAX | Virax Biolabs Group Limited | 2.01M | -0.88% | 162,602 | 2.99K |
| 598 | BDRX | Biodexa Pharmaceuticals Plc | 1.82M | 3.33% | 2,825,387 | 104.90K |
| 599 | MLEC | Moolec Science SA | 1.81M | 4.63% | 454,337 | 7.83M |
| 600 | PBM | Psyence Biomedical Ltd. | 777.16K | -12.69% | 401,117 | - |